Foteini Kyrailidi

Thessaloniki, ESYE12 54642, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.

Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.

Journal: International journal of antimicrobial agents

Published: April 10, 2024

The Role of Helicobacter pylori and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes.

The Role of Helicobacter pylori and Metabolic Syndrome-Related Mast Cell Activation Pathologies and Their Potential Impact on Pregnancy and Neonatal Outcomes.

Journal: Journal of clinical medicine

Published: March 08, 2024

Comment on: Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort.

Comment on: Association between Helicobacter pylori infection and incident risk of dementia: The AMI cohort.

Journal: Journal of the American Geriatrics Society

Published: February 01, 2024

Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology.

Helicobacter pylori and metabolic syndrome-related adipokines in nonalcoholic fatty liver disease pathophysiology.

Journal: Journal of gastroenterology and hepatology

Published: January 28, 2024

Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration.

Impact of Helicobacter pylori and metabolic syndrome on mast cell activation-related pathophysiology and neurodegeneration.

Journal: Neurochemistry international

Published: December 08, 2023

Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels.

Letter: Histological changes among asymptomatic chronic HBV carriers with normal alanine aminotransferase levels.

Journal: Alimentary pharmacology & therapeutics

Published: November 21, 2023

Local and systemic autoimmune manifestations linked to hepatitis A infection.

Local and systemic autoimmune manifestations linked to hepatitis A infection.

Journal: Acta gastro-enterologica Belgica

Published: October 10, 2023

Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.

Potential impact of trained innate immunity on the pathophysiology of metabolic dysfunction-associated fatty liver disease.

Journal: Clinical immunology (Orlando, Fla.)

Published: August 09, 2023

Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.

Autonomic Dysfunction and Somatization in Young Patients With Irritable Bowel Syndrome and Mitral Valve Prolapse Syndrome.

Journal: Journal of neurogastroenterology and motility

Published: July 07, 2023

Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.

Potential impact of Helicobacter pylori infection on hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B.

Journal: Journal of viral hepatitis

Published: March 22, 2023

Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration.

Controlling the Impact of Helicobacter pylori-Related Hyperhomocysteinemia on Neurodegeneration.

Journal: Medicina (Kaunas, Lithuania)

Published: December 24, 2022

Innate immunity and nonalcoholic fatty liver disease.

Innate immunity and nonalcoholic fatty liver disease.

Journal: Annals of gastroenterology

Published: December 13, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026